890090-21-8,
(Ra)-7,7'-Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)-1,1'-spirobiindane,
(R?,S,S)-(+)-SpiroBOX,
(SA,S,S)-SPIROBOX,
DTXSID40586515,
(R)-7,7-Bis[(4S)-(phenyl)oxazol-2-yl)]-2,2,3,3-tetrahydro-1,1-spirobiindane,
CS-213,
AKOS015950882,
AB1005825,
CS-0035249,
7,7'-Bis(4beta-phenyl-2-oxazoline-2-yl)-1,1'-spirobiindan,
(aR)-7,7'-Bis[(4S)-4beta-phenyl-2-oxazoline-2-yl]-1,1'-spirobiindan,
(aS)-7,7'-Bis(4beta-phenyl-2-oxazoline-2-yl)-1,1'-spirobi[indan],
(Sa)-7,7'-Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)-1,1'-spirobiindane,
(4S)-4-phenyl-2-[4\'-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]-3,3\'-spirobi[1,2-dihydroindene]-4-yl]-4,5-dihydro-1,3-oxazole,
(4S,4'S)-2,2'-(2,2',3,3'-Tetrahydro-1,1'-spirobi[indene]-7,7'-diyl)bis(4-phenyl-4,5-dihydro-1,3-oxazole),
(4S,4S)-2,2-[(1R)-2,2,3,3-Tetrahydro-1,1-spirobi[1H-indene]-7,7-diyl]bis[4,5-dihydro-4-phenyloxazole],
(R)-7,7Bis[(4S)-(phenyl)oxazol-2-yl)]-2,23,3tetrahydro-1,1spirobiindane, min. 97% (Ra,S,S)-SpiroBOX,
(Ra,S,S)-7,7 inverted exclamation marka-bis(4 inverted exclamation marka-phenyloxazol-2-yl)-1,1 inverted exclamation marka-spirobiindane,